Results 11 to 20 of about 4,868 (133)

Chronic mucocutaneous candidiasis

open access: yesIndian Journal of Paediatric Dermatology, 2018
Chronic mucocutaneous candidiasis is a rare entity characterized by isolated defective immunity against candida infection. It manifests with resistant and relapsing superficial candida infection affecting skin, hair, nails, and mucosae.
Sarita Sasidharanpillai   +6 more
doaj   +1 more source

Research progress on chronic mucocutaneous candidiasis [PDF]

open access: yes口腔疾病防治
Chronic mucocutaneous candidiasis (CMC) is an infectious phenotype characterized by recurrent or persistent infections caused by Candida species that affect the skin, nails, oral, and genital mucosae for a duration exceeding six months.
RAO Chenxing, LIANG Jing, MO Longhui, WANG Jiongke, ZENG Xin
doaj   +1 more source

Autosomal dominant chronic mucocutaneous candidiasis with STAT1 mutation can be associated with chronic active hepatitis: A case report

open access: yesFrontiers in Pediatrics, 2023
BackgroundChronic mucocutaneous candidiasis (CMC) is a heterogeneous primary immunodeficiency disease characterized by chronic or recurrent Candida infections of the skin, nails, and mucosa and is mostly associated with STAT1 gain-of-function (GOF ...
Lingling Liu   +3 more
doaj   +1 more source

Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis

open access: yesFrontiers in Immunology, 2022
Patients with STAT1 gain-of-function (GOF) mutations suffer from an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). The pathogenesis behind this complex and heterogeneous disease is still incompletely understood.
Marketa Bloomfield   +5 more
doaj   +1 more source

Chronic mucocutaneous candidiasis: a look at genetic understanding

open access: yesIatreia, 2018
Chronic mucocutaneous candidiasis is an infectious phenotype characterized by recurrent or persistent infections in the skin, nails and mucous membranes produced by Candida sp.
Maya Rico, Ana María   +1 more
doaj   +1 more source

Chronic mucocutaneous candidiasis associated with paracoccidioidomycosis in a patient with mannose receptor deficiency: First case reported in the literature

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2021
We describe the first report of a patient with chronic mucocutaneous candidiasis associated with disseminated and recurrent paracoccidioidomycosis. The investigation demonstrated that the patient had a mannose receptor deficiency, which would explain the
Dewton de Moraes Vasconcelos   +2 more
doaj   +1 more source

Clinical and immunological data of nine patients with chronic mucocutaneous candidiasis disease

open access: yesData in Brief, 2016
This paper describes the heterogeneous clinical phenotype of a cohort of nine patients diagnosed with heterozygous mutations in STAT1. We report data of extended immunophenotyping over time and we show lung damage in four patients.
Laura Dotta   +16 more
doaj   +1 more source

Pathogenic and Protective Autoantibodies in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)

open access: yesAntibodies, 2017
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare disorder caused by mutations in the autoimmune regulator (AIRE) gene, leading to defects in T cell selection.
Sakeen W. Kashem, Bryce A. Binstadt
doaj   +1 more source

Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis

open access: yesStem Cell Research, 2020
Chronic mucocutaneous candidiasis (CMC) is a disease that is characterized by susceptibility to chronic or recurrent infections with Candida spp. due to mutations affecting mainly the IL-17 signaling of T-Cells. The most common etiologies of CMC are gain-
Kathrin Haake   +7 more
doaj   +1 more source

Approach to a child with primary immunodeficiency made simple

open access: yesIndian Dermatology Online Journal, 2017
Primary immunodeficiency disorders (PIDs) are a group of disorders affecting the capability to fight against infection. These include defects in T cells and B cells affecting cell-mediated and humoral immunity, respectively, combined humoral and cell ...
Dhrubajyoti Sharma   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy